← Back to Search

Mobile App for Smoking Cessation in HIV

N/A
Recruiting
Led By Micahel Businelle, Ph.D.
Research Sponsored by University of Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weeks 1,2,3,4,5,6, & 28
Awards & highlights

Study Summary

This trial will study if a mobile app can help reduce smoking and anxiety among Black adults with HIV. #HIV #smoking #mobileapp

Who is the study for?
This trial is for Black/African American adults with HIV who smoke daily, want to quit smoking, and have moderate to high anxiety sensitivity. Participants must be over 18, motivated to quit (≥5 on a scale of 10), able to read English, and willing to use nicotine replacement therapy. Pregnant individuals or those planning pregnancy soon, non-English fluent speakers, people undergoing other treatments for smoking cessation or mental health issues are excluded.Check my eligibility
What is being tested?
The study tests a mobile app designed for Black smokers with HIV aiming at reducing anxiety-sensitivity and helping them stop smoking. Participants will be randomly placed into two groups: one using the MASP+ app and the other as a control group without this specialized tool.See study design
What are the potential side effects?
While not explicitly stated in the provided information, potential side effects may include typical reactions associated with quitting smoking such as nicotine withdrawal symptoms like irritability, cravings, difficulty concentrating and increased appetite.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weeks 1,2,3,4,5,6, & 28
This trial's timeline: 3 weeks for screening, Varies for treatment, and weeks 1,2,3,4,5,6, & 28 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Biochemically verified smoking abstinence
Secondary outcome measures
ART Adherence
Index of Engagement in HIV Care
World Health Organization Quality of Life HIV (WHOQOL-HIV)

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: MASP+ app & NRTExperimental Treatment1 Intervention
MASP+ is an intervention designed to assist Black smokers with HIV who experience elevated anxiety sensitivity to quit smoking through the use of educational videos, tailored messages, and interoceptive exercises designed to help the user overcome negative feelings of stress and nicotine withdrawal. Nicotine patches will be made available to provide adjunctive support.
Group II: QuitGuide app + NRTActive Control1 Intervention
The QuitGuide app is a standard-of-care app that allows users to track nicotine cravings and provides motivational messages. Nicotine patches will be made available to provide adjunctive support.

Find a Location

Who is running the clinical trial?

University of HoustonLead Sponsor
147 Previous Clinical Trials
47,406 Total Patients Enrolled
National Institute on Minority Health and Health Disparities (NIMHD)NIH
383 Previous Clinical Trials
1,216,287 Total Patients Enrolled
Baylor College of MedicineOTHER
1,001 Previous Clinical Trials
6,002,140 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can individuals over the age of 75 partake in this research?

"The eligibility criteria for this medical study requires that participants must be of legal age and under the age of retirement."

Answered by AI

Who can qualify for participation in this clinical experiment?

"To qualify for the trial, hopeful participants should be cigarette smokers and within 18-65 years old. There are currently 72 spots available in this research study."

Answered by AI

Is this experiment currently enrolling participants?

"This research is actively searching for participants, according to the information on clinicaltrials.gov. The trial was initially announced on October 16th 2023 and had its most recent update a week later on October 25th."

Answered by AI

How many individuals are conducting this experiment?

"Affirmative. Clinicaltrials.gov shows that this research study, which was introduced on October 16th of 2023, is recruiting participants as we speak. Only 72 patients are needed from one medical centre for the duration of the trial."

Answered by AI

Who else is applying?

What site did they apply to?
Thomas Street at Quentin Mease Health Center
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

Because I would like to quit smoking and I need help so can you help me please.
PatientReceived 2+ prior treatments
Recent research and studies
clinicaltrials.govStudy
Smoking, Stress, HIV and Mobile Technology
Lorra Garey 2023. "Smoking, Stress, HIV and Mobile Technology". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05709002.
~41 spots leftby Dec 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top